These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the dilution behaviour of immuno-stimulating complexes (ISCOMs). Lendemans DG; Egert AM; Myschik J; Hook S; Rades T Pharmazie; 2006 Aug; 61(8):689-95. PubMed ID: 16964712 [TBL] [Abstract][Full Text] [Related]
4. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines. Sjölander A; Cox JC Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684 [TBL] [Abstract][Full Text] [Related]
5. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants. Rivera-Patron M; Cibulski SP; Miraballes I; Silveira F Methods Mol Biol; 2022; 2469():183-191. PubMed ID: 35508839 [TBL] [Abstract][Full Text] [Related]
6. Current status and potential application of ISCOMs in veterinary medicine. Morein B; Hu KF; Abusugra I Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787 [TBL] [Abstract][Full Text] [Related]
7. On the structure of immune-stimulating saponin-lipid complexes (iscoms). Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105 [TBL] [Abstract][Full Text] [Related]
8. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes. Copland MJ; Rades T; Davies NM Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704 [TBL] [Abstract][Full Text] [Related]
9. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis. Demana PH; Davies NM; Berger B; Vosgerau U; Rades T J Pharm Pharmacol; 2004 May; 56(5):573-80. PubMed ID: 15142333 [TBL] [Abstract][Full Text] [Related]
10. ISCOM-based vaccines: the second decade. Sanders MT; Brown LE; Deliyannis G; Pearse MJ Immunol Cell Biol; 2005 Apr; 83(2):119-28. PubMed ID: 15748208 [TBL] [Abstract][Full Text] [Related]
11. ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of Cibulski S; de Souza TA; Raimundo JP; Nascimento YM; Abreu LS; Suarez N; Miraballes I; Roehe PM; de Araújo DAM; Tavares JF; da Silva MS; Silveira F Bionanoscience; 2022; 12(4):1166-1171. PubMed ID: 35967762 [No Abstract] [Full Text] [Related]
13. Pseudo-ternary phase diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by the lipid-film hydration method. Demana PH; Davies NM; Vosgerau U; Rades T Int J Pharm; 2004 Feb; 270(1-2):229-39. PubMed ID: 14726138 [TBL] [Abstract][Full Text] [Related]
14. Influence of Quil A on liposomal membranes. Paepenmüller T; Müller-Goymann CC Int J Pharm; 2014 Nov; 475(1-2):138-46. PubMed ID: 25107288 [TBL] [Abstract][Full Text] [Related]
17. A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix. Liang M; Toth I; Davies NM Eur J Pharm Biopharm; 2008 Mar; 68(3):840-5. PubMed ID: 18182279 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix. Rönnberg B; Fekadu M; Morein B Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296 [TBL] [Abstract][Full Text] [Related]
19. QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar Vesicles. Abucayon EG; Rao M; Matyas GR; Alving CR Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765181 [TBL] [Abstract][Full Text] [Related]
20. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs). Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]